Lifespan-extending drug given late in life reverses age-related heart disease in mice: Rapamycin
June 10, 2013 — Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months. The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent.
There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Researchers at the Mayo Clinic are currently recruiting seniors with cardiac artery disease for a clinical trial involving low dose treatment with rapamycin.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old -- the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period -- using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. "When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period," he said. "This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment," added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. "Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation," said Melov. "We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention."
"Little has been known about the functional ramifications of rapamycin in mammalian tissues," said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. "These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life." He added, "It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life."
Chronic treatment with rapamycin has been problematic in both humans and mice; the drug has the potential to cause deleterious metabolic side effects including weight gain and glucose insensitivity. Melov said in this study, the drug had only mild transient metabolic effects. Future studies will focus on better understanding the molecular targets that drive age-related heart dysfunction, and why rapamycin treatment is so beneficial to the aging hearts.
Contributors to the work: Other Buck Institute researchers involved in the study include James Flynn, who wrote the manuscript, Monique O'Leary, Christopher Zambataro, Emmeline Academia, Michael Presley, Brittany Garrett, Artem Zykovich, Sean Mooney, and Pankaj Kapahi. Other researchers include Randy Strong, Department of Pharmacology and Barshop Institute for Longevity and Aging Studies, UTHSC, San Antonio, TX; Clifford Rosen, Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough, ME; and Michael Nelson, Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA. This work was supported by the following grants from the USA National Institutes of Health: PO1 AG025901, RO1 AG033373, 1U01-AG022307, T32AG000266 and partial support from the Larry L. Hillblom Foundation Network Grant, the Ellison Medical Foundation and the Glenn Foundation for Medical Research.
Welcome to SUV System Ltd!
SUV System Ltd is ISO 90012008 Certified electronics distributor with 10 years of experiences.
We have built up long term business relationship with about many companies which are stockers and authorized agents. we have a steady and reliable supply to meet customer's demands to the greatest extent .Confidently, we are able to lower your cost and support your business with our years of professional service.
SUV System Ltd is Electronic Components Distributor Supplies,Find Quality Electronic Components Supplies Products IC(Integrated Circuits),Connectors,Capacitor,Resistors,Diodes,Transistors,LED at Suvsystem.com. Sourcing Other Energy, Environment, Excess Inventory Products from Manufacturers and Suppliers at Suvsystem.com
Electronic Components distributor:http://www.suvsystem.com
Connectors Distributor:http://www.suvsystem.com/l/Connectors-1.html
IC Distributor:http://www.suvsystem.com/l/IC(Integrated-Circuits)-1.html
LED Distributor:http://www.suvsystem.com/l/LED-1.html
Capacitor Distributor:http://www.suvsystem.com/l/Capacitor-1.html
Transistor Distributor:http://www.suvsystem.com/l/Transistors-1.html
Resistor Distributor:http://www.suvsystem.com/l/Resistors-1.html
Diode Distributor:http://www.suvsystem.com/l/Diodes-1.html
SUV System Ltd insists on the managing faith ofsincereness,speciality,foresight, win-win,so we build up stable-relationship customers located all over the world, including the States, Europe, Argentina, UAE, Malaysia, Australia,and India etc
we are focus on the following fields,and hope we can help you.
CMF55604R00DHR6 CMF55604R00DHEB CMF55604R00DHEA CMF55604R00BEWF70 CMF55604R00BERE70 CMF55604R00BER870 CMF55604R00BER770 CMF55604R00BER670 CMF55604R00BER6 CMF55604R00BEEB70 CMF55604R00BEEB CMF55604R00BEEA70 CMF55604K00FLEK CMF55604K00FLBF CMF55604K00FKWF70 CMF55604K00FKRE70 CMF55604K00FKRE CMF55604K00FKR870 CMF55604K00FKR770 CMF55604K00FKR670 CMF55604K00FKEK CMF55604K00FKEB70 CMF55604K00FKEA70 CMF55604K00FKBF CMF55604K00FHWF CMF55604K00FHRE CMF5560K400FHEA70 CMF5560K400FHEA CMF5560K400FHBF CMF5560K400FEEK CMF5560K400DHWF CMF5560K400DHRE CMF5560K400DHR8 CMF5560K400DHR7 CMF5560K400DHR6 CMF5560K400DHEK CMF5560K400DHEB CMF5560K400DHEA CMF5560K400CHEA CMF5560K400BEWF70
http://www.suvsystem.com/a/2491.aspx
